Though not an all inclusive list, VCHCP does not cover the following alternative medicine interventions, because there is inadequate evidence in the peer-reviewed published medical literature of their effectiveness: products that are not typically considered to be part of traditional Western medicine (i.e., conventional medicine). CAM assessments and therapies are proposed to reduce disease-based clinical symptoms and improve health and wellness. Complementary medicine may be used in conjunction with Western medicine, as opposed to alternative medicine which may be used in place of Western medicine. Integrative medicine, as defined by the National Center for Complementary and Alternative Medicine (NCCAM), combines conventional medical therapies and CAM therapies for which there is scientific evidence of safety and effectiveness. Various CAM therapies are supported by some degree of scientific evidence, but for most CAM therapies key questions regarding the safety and efficacy of these therapies for specific conditions are yet to be answered through well-designed scientific studies (NCCAM, 2010).
Classifications of CAM practices include the following:
• • Whole Medical Systems: Whole medical systems are built upon complete systems of theory and practice. Often, these systems have evolved apart from, and earlier than, the conventional medical approach used in the United States. •
• Biologically-Based Practices: Biologically based practices in CAM use substances found in nature including herbs, foods, and vitamins. Examples of these substances include dietary supplements, herbal products, and other natural products that have not been scientifically proven (e.g., using shark cartilage to treat cancer). •
• Energy Medicine: Energy medicine involves the use of energy fields and consist of two types of therapies: Biofield therapies are intended to affect energy fields that purportedly surround and penetrate the human body. The existence of such fields has not yet been scientifically proven. Some forms of energy therapy are proposed to manipulate biofields by applying pressure, heat or body manipulation.
Bioelectromagnetic-based therapies involve the unconventional use of electromagnetic fields, such as pulsed fields, magnetic fields, or alternating current or direct current fields. •
• Manipulative and Body-Based Methods: Manipulative and body-based methods are based on manipulation and/or movement of one or more parts of the body.
• Mind-Body Medicine: Mind-body medicine uses a variety of techniques designed to enhance the mind's capacity to affect bodily function and symptoms.
•
U.S. Food and Drug Administration (FDA)
• The Federal Food and Drug Act of 1906, The Wiley Act, empowers the FDA Center for Food Safety and Nutrition to remove unsafe food substances and botanicals from the market, and gives the FDA regulatory oversight for substances added to food, including monitoring safe use. The FDA maintains that a drug is any substance or mixture of , the burden of proof rests on the FDA to show that a product is unsafe. Manufacturers are not required to submit substantiation of benefit data to the FDA. The Federal Trade Commission (FTC) is charged with accurate marketing and advertising claims (FDA, 2009). • According to the FDA, dietary supplements in today's market include one or a combination of: vitamins, minerals, herbals, botanicals, amino acids, any dietary substance used to supplement the diet by increasing total dietary intake, and a concentrate, metabolite, constituent or extract. The FDA states that, while some supplements may help ensure that the individual consumes adequate amounts of essential nutrients needed for optimal health and performance, dietary supplements cannot be promoted as a treatment or a cure (FDA, 2009).
• In December 2006, the FDA issued a draft guidance document for the regulation of CAM products. The draft was issued because increased use of CAM in the United States has caused confusion regarding which products are subject to regulation under the Federal Food, Drug, and Cosmetic Act (Act) or the Public Health Service Act (PHS Act) and because the number of CAM products being imported into the United States has increased. The document provides guidance as to when a CAM product is subject to the Act or the PHS Act. The FDA cites the NCCAM's definition and categories of CAM in the draft. According to the new guidance, if the labeling of a dietary supplement includes the term "to treat," that supplement will be regulated as a drug under the Act. Biological products (e.g., virus, therapeutic serum, toxin, antitoxin, vaccine) will be regulated under the PHS Act (FDA, 2009; FDA, 2007) .
The efficacy of various alternative medicine regimens ranges from extremely effective to ineffective or even harmful. VCHCP makes no statement regarding the medical necessity or effect of such alternative medicine interventions. 
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